Search results
Screening Completed: Berlin Cures Achieves Key Milestone in BC 007 Phase II Trial for Treatment of...
Digital Journal· 5 days agoBy addressing the underlying cause of fAAB-associated diseases with this unique biotechnology, Berlin Cures emerges as one of the pioneering entities committed to addressing ...
Screening Completed: Berlin Cures Achieves Key Milestone in BC 007 Phase II Trial for Treatment of...
Morningstar· 5 days agoBERLIN, GERMANY / ACCESSWIRE / April 23, 2024 / Berlin Cures, a pioneering clinical-stage biotechnology company, today announced the successful completion of patient screening for its pan-European ...